Toward an Extended Definition of Major Depressive Disorder Symptomatology: Digital Assessment and Cross-validation Study (Preprint)
Authors:
- Nayra A Martin-KeyNMNayra A Martin-Key
- Dan-Mircea MireaDMDan-Mircea Mirea
- Tony OlmertTOTony Olmert
- Jason CooperJCJason Cooper
- Sung Yeon Sarah HanSHSung Yeon Sarah Han
- Giles Barton-OwenGBGiles Barton-Owen
- Lynn FarragLFLynn Farrag
- Emily BellEBEmily Bell
- Pawel EljaszPEPawel Eljasz
- Daniel CowellDCDaniel Cowell
- Jakub TomasikJTJakub Tomasik
- Sabine BahnSBSabine Bahn
Preprint
- 15 February 2021
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Diagnosing major depressive disorder (MDD) is challenging, with diagnostic manuals failing to capture the wide range of clinical symptoms that are endorsed by individuals with this condition. OBJECTIVE This study aims to provide evidence for an extended definition of MDD symptomatology. METHODS Symptom data were collected via a digital assessment developed for a delta study. Random forest classification with nested cross-validation was used to distinguish between individuals with MDD and those with subthreshold symptomatology of the disorder using disorder-specific symptoms and transdiagnostic symptoms. The diagnostic performance of the Patient Health Questionnaire–9 was also examined. RESULTS A depression-specific model demonstrated good predictive performance when distinguishing between individuals with MDD (n=64) and those with subthreshold depression (n=140) (area under the receiver operating characteristic curve=0.89; sensitivity=82.4%; specificity=81.3%; accuracy=81.6%). The inclusion of transdiagnostic symptoms of psychopathology, including symptoms of depression, generalized anxiety disorder, insomnia, emotional instability, and panic disorder, significantly improved the model performance (area under the receiver operating characteristic curve=0.95; sensitivity=86.5%; specificity=90.8%; accuracy=89.5%). The Patient Health Questionnaire–9 was excellent at identifying MDD but overdiagnosed the condition (sensitivity=92.2%; specificity=54.3%; accuracy=66.2%). CONCLUSIONS Our findings are in line with the notion that current diagnostic practices may present an overly narrow conception of mental health. Furthermore, our study provides proof-of-concept support for the clinical utility of a digital assessment to inform clinical decision-making in the evaluation of MDD.Keywords
All Related Versions
- Published version: JMIR Formative Research, 5 (10), e27908.
This publication has 60 references indexed in Scilit:
- A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational StudyJMIR Research Protocols, 2020
- Depression is more than the sum score of its parts: individual DSM symptoms have different risk factorsPsychological Medicine, 2013
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010PLOS Medicine, 2013
- A Genome-Wide Association Study of Depressive SymptomsBiological Psychiatry, 2013
- A mega-analysis of genome-wide association studies for major depressive disorderMolecular Psychiatry, 2012
- Genome-Wide Association Study of Major Recurrent Depression in the U.K. PopulationAmerican Journal of Psychiatry, 2010
- Genome-wide association study of recurrent early-onset major depressive disorderMolecular Psychiatry, 2010
- Clinical diagnosis of depression in primary care: a meta-analysisThe Lancet, 2009
- Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveysThe Lancet, 2007
- Subsyndromal depression: prevalence, use of health services and quality of life in an Australian populationSocial Psychiatry and Psychiatric Epidemiology, 2004